{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T13:21:35Z","timestamp":1791897695049,"version":"4.3.4"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,5,2]],"date-time":"2018-05-02T00:00:00Z","timestamp":1525219200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"the Science and Technology Commission of Shanghai Municipality","award":["No. 15411962400"],"award-info":[{"award-number":["No. 15411962400"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Radiat Oncol"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s13014-018-1030-1","type":"journal-article","created":{"date-parts":[[2018,5,2]],"date-time":"2018-05-02T01:51:49Z","timestamp":1525225909000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":74,"title":["Preexisting radiological interstitial lung abnormalities are a risk factor for severe radiation pneumonitis in patients with small-cell lung cancer after thoracic radiation therapy"],"prefix":"10.1186","volume":"13","author":[{"given":"Fangjuan","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziyang","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ailu","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongyu","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shixiong","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,5,2]]},"reference":[{"key":"1030_CR1","doi-asserted-by":"publisher","first-page":"1741","DOI":"10.1016\/S0140-6736(11)60165-7","volume":"378","author":"JP van Meerbeeck","year":"2011","unstructured":"van Meerbeeck JP, Fennell DA, De Ruysscher DK. Small-cell lung cancer. Lancet. 2011;378:1741\u201355.","journal-title":"Lancet"},{"key":"1030_CR2","doi-asserted-by":"publisher","first-page":"4106","DOI":"10.1200\/JCO.2015.63.7918","volume":"33","author":"CM Rudin","year":"2015","unstructured":"Rudin CM, Ismaila N, Hann CL, et al. Treatment of small-cell lung Cancer: American Society of Clinical Oncology endorsement of the American College of Chest Physicians Guideline. J Clin Oncol. 2015;33:4106\u201311.","journal-title":"J Clin Oncol"},{"key":"1030_CR3","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1056\/NEJM199901283400403","volume":"340","author":"AT Turrisi 3rd","year":"1999","unstructured":"Turrisi AT 3rd, Kim K, Blum R, et al. Twice-daily compared with once-daily thoracic radiotherapy in limited small-cell lung cancer treated concurrently with cisplatin and etoposide. N Engl J Med. 1999;340:265\u201371.","journal-title":"N Engl J Med"},{"key":"1030_CR4","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1016\/S1470-2045(17)30318-2","volume":"18","author":"C Faivre-Finn","year":"2017","unstructured":"Faivre-Finn C, Snee M, Ashcroft L, et al. Concurrent once-daily versus twice-daily chemoradiotherapy in patients with limited-stage small-cell lung cancer (CONVERT): an open-label, phase 3, randomised, superiority trial. Lancet Oncol. 2017;18:1116\u201325.","journal-title":"Lancet Oncol"},{"key":"1030_CR5","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1016\/j.ijrobp.2004.01.055","volume":"59","author":"SE Schild","year":"2004","unstructured":"Schild SE, Bonner JA, Shanahan TG, et al. Long-term results of a phase III trial comparing once-daily radiotherapy with twice-daily radiotherapy in limited-stage small-cell lung cancer. Int J Radiat Oncol Biol Phys. 2004;59:943\u201351.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1030_CR6","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1016\/j.ijrobp.2012.04.043","volume":"85","author":"DA Palma","year":"2013","unstructured":"Palma DA, Senan S, Tsujino K, et al. Predicting radiation pneumonitis after chemoradiation therapy for lung cancer: an international individual patient data meta-analysis. Int J Radiat Oncol Biol Phys. 2013;85:444\u201350.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1030_CR7","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1016\/j.cllc.2014.11.008","volume":"16","author":"ME Giuliani","year":"2015","unstructured":"Giuliani ME, Lindsay PE, Kwan JY, et al. Correlation of dosimetric and clinical factors with the development of esophagitis and radiation pneumonitis in patients with limited-stage small-cell lung carcinoma. Clin Lung Cancer. 2015;16:216\u201320.","journal-title":"Clin Lung Cancer"},{"key":"1030_CR8","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1016\/j.ijrobp.2005.09.025","volume":"64","author":"K Tsujino","year":"2006","unstructured":"Tsujino K, Hirota S, Kotani Y, et al. Radiation pneumonitis following concurrent accelerated hyperfractionated radiotherapy and chemotherapy for limited-stage small-cell lung cancer: dose-volume histogram analysis and comparison with conventional chemoradiation. Int J Radiat Oncol Biol Phys. 2006;64:1100\u20135.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1030_CR9","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1016\/j.radonc.2008.09.009","volume":"91","author":"H Jin","year":"2009","unstructured":"Jin H, Tucker SL, Liu HH, et al. Dose-volume thresholds and smoking status for the risk of treatment-related pneumonitis in inoperable non-small cell lung cancer treated with definitive radiotherapy. Radiother Oncol. 2009;91:427\u201332.","journal-title":"Radiother Oncol"},{"key":"1030_CR10","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/j.ijrobp.2012.03.041","volume":"85","author":"R Baker","year":"2013","unstructured":"Baker R, Han G, Sarangkasiri S, et al. Clinical and dosimetric predictors of radiation pneumonitis in a large series of patients treated with stereotactic body radiation therapy to the lung. Int J Radiat Oncol Biol Phys. 2013;85:190\u20135.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1030_CR11","doi-asserted-by":"publisher","first-page":"2103","DOI":"10.1007\/s00432-012-1284-1","volume":"138","author":"XJ Zhang","year":"2012","unstructured":"Zhang XJ, Sun JG, Sun J, et al. Prediction of radiation pneumonitis in lung cancer patients: a systematic review. J Cancer Res Clin Oncol. 2012;138:2103\u201316.","journal-title":"J Cancer Res Clin Oncol"},{"key":"1030_CR12","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1002\/(SICI)1097-0142(19980301)82:5<842::AID-CNCR7>3.0.CO;2-L","volume":"82","author":"JM Monson","year":"1998","unstructured":"Monson JM, Stark P, Reilly JJ, et al. Clinical radiation pneumonitis and radiographic changes after thoracic radiation therapy for lung carcinoma. Cancer. 1998;82:842\u201350.","journal-title":"Cancer"},{"issue":"2","key":"1030_CR13","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1148\/radiol.13120816","volume":"268","author":"GY Jin","year":"2013","unstructured":"Jin GY, Lynch D, Chawla A, et al. Interstitial lung abnormalities in a CT lung cancer screening population: prevalence and progression rate[J]. Radiology. 2013;268(2):563.","journal-title":"Radiology"},{"key":"1030_CR14","doi-asserted-by":"publisher","first-page":"2534","DOI":"10.1016\/j.rmed.2007.07.012","volume":"101","author":"I Le Jeune","year":"2007","unstructured":"Le Jeune I, Gribbin J, West J, et al. The incidence of cancer in patients with idiopathic pulmonary fibrosis and sarcoidosis in the UK. Respir Med. 2007;101:2534\u201340.","journal-title":"Respir Med"},{"key":"1030_CR15","doi-asserted-by":"crossref","unstructured":"Choi WI, Park SH, Park BJ, Lee CW. Interstitial lung disease and lung Cancer development: a 5-year Nationwide population-based study. Cancer Res Treat. 2018;50:374\u201381.","DOI":"10.4143\/crt.2017.119"},{"issue":"5","key":"1030_CR16","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1016\/j.ejrad.2015.01.021","volume":"84","author":"M Nishino","year":"2015","unstructured":"Nishino M, Cardarella S, Dahlberg SE, et al. Interstitial lung abnormalities in treatment-na\u00efve advanced non-small-cell lung cancer patients are associated with shorter survival[J]. Eur J Radiol. 2015;84(5):998.","journal-title":"Eur J Radiol"},{"key":"1030_CR17","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1164\/rccm.201108-1420PP","volume":"185","author":"TJ Doyle","year":"2012","unstructured":"Doyle TJ, Hunninghake GM, Rosas IO. Subclinical interstitial lung disease: why you should care. Am J Respir Crit Care Med. 2012;185:1147\u201353.","journal-title":"Am J Respir Crit Care Med"},{"key":"1030_CR18","doi-asserted-by":"publisher","first-page":"e0140437","DOI":"10.1371\/journal.pone.0140437","volume":"10","author":"Y Ozawa","year":"2015","unstructured":"Ozawa Y, Abe T, Omae M, et al. Impact of preexisting interstitial lung disease on acute, extensive radiation pneumonitis: retrospective analysis of patients with lung Cancer. PLoS One. 2015;10:e0140437.","journal-title":"PLoS One"},{"key":"1030_CR19","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1016\/j.lungcan.2013.08.024","volume":"82","author":"S Yamaguchi","year":"2013","unstructured":"Yamaguchi S, Ohguri T, Ide S, et al. Stereotactic body radiotherapy for lung tumors in patients with subclinical interstitial lung disease: the potential risk of extensive radiation pneumonitis. Lung Cancer. 2013;82:260\u20135.","journal-title":"Lung Cancer"},{"key":"1030_CR20","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1097\/JTO.0000000000000359","volume":"10","author":"N Ueki","year":"2015","unstructured":"Ueki N, Matsuo Y, Togashi Y, et al. Impact of pretreatment interstitial lung disease on radiation pneumonitis and survival after stereotactic body radiation therapy for lung cancer. J Thorac Oncol. 2015;10:116\u201325.","journal-title":"J Thorac Oncol"},{"key":"1030_CR21","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/1748-717X-5-32","volume":"5","author":"H Yamashita","year":"2010","unstructured":"Yamashita H, Kobayashi-Shibata S, Terahara A, et al. Prescreening based on the presence of CT-scan abnormalities and biomarkers (KL-6 and SP-D) may reduce severe radiation pneumonitis after stereotactic radiotherapy. Radiat Oncol. 2010;5:32.","journal-title":"Radiat Oncol"},{"key":"1030_CR22","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1164\/rccm.201308-1483ST","volume":"188","author":"WD Travis","year":"2013","unstructured":"Travis WD, Costabel U, Hansell DM, et al. An official American Thoracic Society\/European Respiratory Society statement: update of the international multidisciplinary classification of the idiopathic interstitial pneumonias. Am J Respir Crit Care Med. 2013;188:733\u201348.","journal-title":"Am J Respir Crit Care Med"},{"issue":"6","key":"1030_CR23","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1164\/rccm.2009-040GL","volume":"183","author":"G Raghu","year":"2011","unstructured":"Raghu G, Collard HR, Egan JJ, et al. ATS\/ERS\/JRS\/ALAT committee on idiopathic pulmonary fibrosis. An official ATS\/ERS\/JRS\/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management. Am J Respir Crit Care Med. 2011;183(6):788\u2013824.","journal-title":"Am J Respir Crit Care Med"},{"key":"1030_CR24","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1007\/s00408-013-9518-9","volume":"192","author":"A Gazula","year":"2014","unstructured":"Gazula A, Baldini EH, Chen A, Kozono D. Comparison of once and twice daily radiotherapy for limited stage small-cell lung cancer. Lung. 2014;192:151\u20138.","journal-title":"Lung"},{"key":"1030_CR25","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1111\/1759-7714.12262","volume":"6","author":"D Han","year":"2015","unstructured":"Han D, Hao S, Tao C, et al. Comparison of once daily radiotherapy to 60 Gy and twice daily radiotherapy to 45 Gy for limited stage small-cell lung cancer. Thorac Cancer. 2015;6:643\u20138.","journal-title":"Thorac Cancer"},{"issue":"2","key":"1030_CR26","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1007\/s00066-016-1069-6","volume":"193","author":"B Sas-Korczy\u0144ska","year":"2017","unstructured":"Sas-Korczy\u0144ska B, \u0141uczy\u0144ska E, Kamzol W, et al. Analysis of risk factors for pulmonary complications in patients with limited-stage small cell lung cancer : a single-Centre retrospective study. Strahlenther Onkol. 2017;193(2):141\u20139.","journal-title":"Strahlenther Onkol"},{"key":"1030_CR27","doi-asserted-by":"publisher","first-page":"1553","DOI":"10.1097\/JTO.0b013e318220c9f6","volume":"6","author":"NP Amin","year":"2011","unstructured":"Amin NP, Miften M, Kavanagh B, et al. Impact of induction chemotherapy on estimated risk of radiation pneumonitis in small cell lung cancer. J Thorac Oncol. 2011;6:1553\u201362.","journal-title":"J Thorac Oncol"}],"container-title":["Radiation Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13014-018-1030-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13014-018-1030-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13014-018-1030-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T23:16:10Z","timestamp":1556752570000},"score":1,"resource":{"primary":{"URL":"https:\/\/ro-journal.biomedcentral.com\/articles\/10.1186\/s13014-018-1030-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5,2]]},"references-count":27,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["1030"],"URL":"https:\/\/doi.org\/10.1186\/s13014-018-1030-1","relation":{},"ISSN":["1748-717X"],"issn-type":[{"value":"1748-717X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,5,2]]},"assertion":[{"value":"27 January 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 April 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 May 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"82"}}